Company Lookup
عربي
Download Demo
 

Market News

This Month News

This Month News

send to a friend by email

Jerusalem Pharmaceuticals Company achieves a net income of JD0.88 million in H1 2013

2013-08-15

According to company data for the first six months of the year, net profit after taxes reached 879,087 USD, compared with a net loss of (853,058) USD from the first six months of 2012. Total assets of the company reached 52,614,881 USD as of June 30th, 2013, compared to total assets of 48,875,519 USD as of December 31st, 2012, a net increase of 7.7%. Total liabilities of the company reached 17,302,521 USD as of June 30th, 2013, compared to total liabilities of 15,164,804 USD as of December 31st, 2012, a net increase of 14.1%. Net ownership equity of the company reached 35,312,360 USD (including 837,484 USD in Non-controlling interest) as of June 30th, 2013, compared with a net ownership equity of 33,710,715 USD (including 951,501 USD in Non-controlling interest) as of December 31st, 2012, a net increase of 4.8% in the last six months. Furthermore, paid-in capital increased from 8,530,000 USD on December 31st, 2012 to 17,060,000 USD by June 30th, 2013, an increase of 100.0%.

 


 

2017-06-22
Al-Quds Index at its highest level in three years

2017-06-21
Al-fiter holiday announcement

2017-06-19
Delisting the Arab Palestinian Shopping Center BRAVO from the PEX

2017-06-15
Al-Quds Index rebounds upwards in mid-June

2017-06-08
Al-Quds Index in the red zone in the second week of Ramadan

2017-06-01
New anticipations appear with the start of June

 

 

 
Sahem Trading & Investments Company - PEX Member and licensed by PCMA
© All Rights Reserved 2013